Hospira Issues A Voluntary Nationwide Recall Of One Lot Of 1% Lidocaine HCL Injection Due To The Presence Of Dark Particulate

Hospira, Inc.(NYSE: HSP), announced today it has initiated a voluntary nationwide recall of one lot of 1% Lidocaine HCI Injection, USP, 10 mg/mL, 20 mL Multiple-dose Fliptop Vial, NDC 0409-4276-01 Lot 25-090-DK (the lot number may be followed by 01 or 02).

http://www.fda.gov/Safety/Recalls/ucm370780.htm

Source: Food and Drug Administration - October 4, 2013 Category: Food Science Source Type: news

More News: Food and Drug Administration (FDA) | Food Science | Lidoderm